In pancreatic samples from patients with advanced tumor stages there are significantly higher levels of the NK-1 receptor, where higher rates of NK-1 receptor expression are associated with advanced tumor stages and a poorer prognosis [10,14,64]. The gene discussed is TACR1; the disease is neoplasm.